COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 366: Articles 3651-3660  | Next

Association between relative income and mental health in adults during the COVID-19 pandemic in Korea: Insights from a community health survey
Moon, M., Choi, M.
10.1101/2023.07.14.23292685 — Posted: 2023-07-16
Clinical manifestations and mortality among hospitalized COVID-19 patients in Tanzania, 2021-2022.
Osati, E. O., Shayo, G. A., Nagu, T., Sangeda, R. Z., Moshiro, C., Vumilia, L., Samwel, L., Mhame, P., Nkya, M. E., Rainer, D., John, M., Mbije, C., Nyaisonga, G., Kilonzo, K. G., Nicholaus, M. A., Seni, J., Muniko, A., Wajanga, B., Ramadhani, A., Adams, N., Shekalaghe, S., Makubi, A.
10.1101/2023.07.13.23292643 — Posted: 2023-07-16
Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults
Datwani, S., Kalikawe, R., Mwimanzi, F., Speckmaier, S., Liang, R., Sang, Y., Waterworth, R., Yaseen, F., Lapointe, H. R., Barad, E., DeMarco, M. L., Holmes, D. T., Simons, J., Montaner, J. S., Romney, M. G., Brumme, Z. L., Brockman, M. A.
10.1101/2023.07.14.23292660 — Posted: 2023-07-16
Oral immunization with rVSV bivalent vaccine elicits protective immune responses, including ADCC, against both SARS-CoV-2 and Influenza A viruses
Ouyang, M. J., Ao, Z., Olukitibi, T., Lawrynuik, P., Shieh, C., Kung, S., Fowke, K., Kobasa, D., Yao, X.
10.1101/2023.07.14.549076 — Posted: 2023-07-15
Absence of SARS-CoV-2 in Wildlife of Northeastern Minnesota and Isle Royale National Park
Castaneda, D., Isaac, E. J., Kautz, T., Romanski, M. C., Moore, S. A., Aliota, M.
10.1101/2023.07.14.549077 — Posted: 2023-07-15
Environmental Surface Monitoring as a Noninvasive Method for SARS-CoV-2 Surveillance in Community Settings: Lessons from a University Campus Study
Ali, S., Cella, E., Johnston, C., Deichen, M., Azarian, T.
10.1101/2023.07.13.23292575 — Posted: 2023-07-14
Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.
Davina-Nunez, C., Perez, S., Cabrera-Alvargonzalez, J. J., Rincon-Quintero, A., Treinta-Alvarez, A., Godoy-Diz, M., Suarez-Luque, S., Regueiro-Garcia, B.
10.1101/2023.07.14.549026 — Posted: 2023-07-14
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
Avila-Herrera, A., Kimbrel, J., Manuel Marti, J., Thissen, J., Saada, E., Weisenberger, T., Arrildt, K., Segelke, B., Allen, J., Zemla, A. K., Borucki, M. K.
10.1101/2023.07.14.549044 — Posted: 2023-07-14
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Ketaren, N. E., Mast, F. D., Fridy, P. C., Olivier, J. P., Sanyal, T., Sali, A., Chait, B. T., Rout, M. P., Aitchison, J.
10.1101/2023.07.14.549041 — Posted: 2023-07-14
Multivalent Exosome based protein vaccine: a "mix and match" approach to epidemic viruses' challenges.
Cacciottolo, M., Hsieh, L.-E., Li, Y., LeCalire, M. J., Nice, J. B., Twaddle, R., Mora, C. L., Young, M., Angeles, J., Lau, C., Jin, C., Elliott, K., sun, m.
10.1101/2023.07.13.548895 — Posted: 2023-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).